Document Detail


Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion.
MedLine Citation:
PMID:  23154502     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To evaluate the long-term visual prognosis and complications of patients who received intravitreal Ozurdex injections for the treatment of macular edema (ME) due to retinal vein occlusion (RVO).
METHODS: A total of 17 patients who received Ozurdex injections in our institution as part of the GENEVA study were recalled for examination. Recorded parameters included final visual acuity (VA), final retinal thickness by optical coherence tomography, persistence of ME, and the occurrence of any complications.
RESULTS: Mean follow-up time was 50.5 months. Patients with branch RVO (BRVO) had a more favorable prognosis than central RVO (CRVO), and their mean VA had improved significantly, whereas the mean VA for the patients with CRVO did not improve significantly. Retinal thickness had reduced significantly in the whole group and in each subgroup separately. Complications included 10 patients with cataract progression, 1 with elevated intraocular pressure, and 1 with neovascularization and vitreous hemorrhage.
CONCLUSIONS: This is the first reported long-term evaluation of patients treated with Ozurdex. Our results indicate that it has favorable long-term safety profile, and may have a beneficial effect on the visual prognosis in BRVO even in the absence of continuous treatment. Further research is required to establish the optimal retreatment schedule for Ozurdex.
Authors:
E Moisseiev; M Goldstein; M Waisbourd; A Barak; A Loewenstein
Publication Detail:
Type:  Journal Article     Date:  2012-11-16
Journal Detail:
Title:  Eye (London, England)     Volume:  27     ISSN:  1476-5454     ISO Abbreviation:  Eye (Lond)     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-01-10     Completed Date:  2013-06-04     Revised Date:  2014-01-09    
Medline Journal Info:
Nlm Unique ID:  8703986     Medline TA:  Eye (Lond)     Country:  England    
Other Details:
Languages:  eng     Pagination:  65-71     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Anti-Inflammatory Agents / administration & dosage*
Dexamethasone / administration & dosage*
Drug Implants
Female
Follow-Up Studies
Humans
Intravitreal Injections
Macular Edema / drug therapy*,  etiology
Male
Middle Aged
Prognosis
Retinal Vein Occlusion / complications*
Visual Acuity
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Drug Implants; 7S5I7G3JQL/Dexamethasone
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  5 years review of periocular basal cell carcinoma and proposed follow-up protocol.
Next Document:  Intra-familial tests of association between familial idiopathic scoliosis and linked regions on 9q31...